Available Clinical Trials
Available Clinical Trials
- A Randomized Study Evaluating Patients Discharged with Indwelling Chest Tube and Valve
PI: K. Robert Shen, MD, Mayo Clinic Rochester
Phase
Phase II
Methodology
Randomized
Overall Study Duration
5 years
Subject Participation Duration
30 Days
Objectives
Primary Objective
To assess the efficacy of antibiotics and closer monitoring on decreasing empyema in patients discharging with a chest tube and valve in place as measured by documented empyema following discharge.
Secondary Objective
To assess the efficacy of antibiotics and closer monitoring on decreasing hospital readmissions while the chest tube and valve are in place as measured by readmission to the hospital following hospital discharge after the initial surgical intervention.
Number of Subjects
560
Diagnosis and Main Inclusion Criteria
Discharge from the hospital with an indwelling chest tube and valve in place
Study Treatment
Oral antibiotics and close monitoring (defined as twice weekly telephone calls by a member of the care team)
Reference Treatment
Standard of Care (defined as no calls from the care team but waiting for the subject to contact the care team when the air leak has stopped)
Statistical Methodology
Comparison of the rate of empyema and readmission in the two arms of the study
- Protocal
- Consent
- Schema
- Contact for more Information